Specialized care for all major neurological disorders offered at new neuroscience facility at Saint Luke's hospital
KANSAS CITY, Mo.
Jan. 9, 2013
/PRNewswire-USNewswire/ -- Designed to serve as one of the preeminent neuroscience centers in the country, the Saint Luke's Neuroscience Institute tower officially opens today at Saint Luke's Hospital. The new facility, specializing in streamlined care for neurological disorders, offers the
community and the entire region a dedicated neuroscience hospital, created to lead the way in research, medical advancements, patient outcomes, comfort, and quality of care.
The Saint Luke's Neuroscience Institute (SLNI), formally known as Saint Luke's Brain and Stroke Institute, came to fruition as the result of a
commitment from the hospital to fund the project. In addition a
fundraising campaign began in
to support the building project as well as to further clinical program development and research. The design and formulation of the new facility was based upon the concept of integrated care delivery and allows the neuroscience program to consolidate its diagnostic, surgical, interventional, intensive care and other services into one 88,000 square foot tower.
ACI/Boland, Inc. served as project architect and J.E. Dunn Construction Co. as general contractor of the
project. The renovation took a year to complete and was created with input from physicians, nurses and staff to construct a space that offers the best environment for providing care and provides families and patients with relaxing, comforting surroundings.
The new facility will not only offer state-of-the-art equipment and expanded facilities but the streamlined design will also provide direct benefit to Saint Luke's neurological patients.
"By treating and caring for our patients with neurological conditions in one dedicated space we have the opportunity to not only provide the best, most comprehensive care in the most timely manner, but those patients will also have the benefit of the clinical expertise and collaboration of all the specialists in the building," said
, M.D., Saint Luke's Neuroscience Institute medical director. "When you are able to bring together leaders and experts in this highly specialized field and allow them to easily collaborate and confer with one another on particular cases or treatment options, the end result is the very best, highest level of care for the patient."
The vision for SLNI is to continue to spearhead advancements in the diagnosis and treatment of neurological and spinal disease, including stroke, epilepsy, Parkinson's Disease, Alzheimer's Disease, brain tumors, aneurysms, headaches, multiple sclerosis and sleep disorders.